Evidence map›Paper›PMID 31213669›Full record

ArticleActa pharmacologica Sinica2020

6-O-angeloylplenolin exerts neuroprotection against lipopolysaccharide-induced neuroinflammation in vitro and in vivo.

Yi-le Zhou, Yong-Ming Yan, Si-Yi Li, Dan-Hua He, Sha Xiong, Su-Fen Wei, Wei Liu, Ling Hu, Qi Wang, Hua-Feng Pan and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Molecules (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. HJournal of molecular neuroscience : MN · 2023
    Article
  13. Review
  14. International journal of molecular sciences · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yi-le Zhou *Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Yong-Ming Yan *School of Pharmaceutical Sciences, Shenzhen University Health Science Center, Shenzhen, 518060, China.
Si-Yi LiInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Dan-Hua HeInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Sha XiongInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Su-Fen WeiInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Wei LiuInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Ling HuInstitute of Gastroenterology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Qi WangInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Hua-Feng PanInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. gzphf@gzucm.edu.cn.
Yong-Xian ChengSchool of Pharmaceutical Sciences, Shenzhen University Health Science Center, Shenzhen, 518060, China. yxcheng@szu.edu.cn.
Yong-Qiang LiuInstitute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. liuyq@gzucm.edu.cn.
Guangzhou University of Chinese Medicine · CNShenzhen University Health Science Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroinflammation is one of the critical events in neurodegenerative diseases, whereas microglia play an important role in the pathogenesis of neuroinflammation. In this study, we investigated the effects of a natural sesquiterpene lactone, 6-O-angeloylplenolin (6-OAP), isolated from the traditional Chinese medicine Centipeda minima (L.) A.Br., on neuroinflammation and the underlying mechanisms. We showed that treatment with lipopolysaccharide (LPS) caused activation of BV2 and primary microglial cells and development of neuroinflammation in vitro, evidenced by increased production of inflammatory cytokines TNF-α and IL-1β, the phosphorylation and nuclear translocation of NF-κB, and the transcriptional upregulation of COX-2 and iNOS, leading to increased production of proinflammatory factors NO and PGE

Indexed as

AnimalsAsteraceaeCells, CulturedCell SurvivalCoculture TechniquesDose-Response Relationship, DrugInflammationLactonesLipopolysaccharidesMaleMedicine, Chinese TraditionalMiceMice, Inbred C57BLMolecular ConformationNeurodegenerative DiseasesNeuroprotective Agents6-O-angeloylprenolinLactonesLipopolysaccharidesNeuroprotective AgentsNitric OxideSesquiterpenes6-O-angeloylplenolindexamethansoneLPSmicroglianeuroinflammationNF-κBoxidative stressTraditional Chinese medicine

Identifiers

PMID31213669
PMCPMC7470812
OpenAlexW2951728066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.